The Endoskeleton® TA ALIF Interbody Fusion Device is approved for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-S1. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). Patients should have received six months of non-operative treatment prior to treatment with the devices. The device may be used with supplemental fixation. The Endoskeleton TA ALIF Device sits on the strongest portion of the endplate yielding excellent resistance to subsidence.The manufacturer is offering a warranty and through the warranty, the manufacturer provides a one-time free replacement of any eligible Endoskeleton spinal interbody fusion device if revision surgery is required within the five year warranty period, as outlined within the terms of the agreement.
Previously available from Titan Spine, LLC.